Published in Biotech Business Week, November 29th, 2004
The company successfully completed the purchase of the Horizon technology and an associated research team from Millennium Pharmaceuticals, Inc., for approximately $9.5 million and future funding commitments.
It has expanded its international presence by forming Gene Logic, KK, a Japan-based subsidiary focused on customer support in the Far East, and by hiring additional business development staff in Germany and the U.K., focused on sales and customer support in Europe.
The company signed NV, Organon to a comprehensive, multiyear...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.